Research Article
Predictive Values of Serum IL-33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps
Table 6
Unadjusted and adjusted multivariate logistic regression analysis of risk factors associated with CRSwNP recurrence.
| | Factor | Unadjusted | Adjusted | | OR (95% CI) | | OR (95% CI) | |
| | Atopy | 1.854 (0.916-4.956) | 0.419 | 1.592 (0.897-4.045) | 0.710 | | Allergic rhinitis | 1.529 (1.067-6.187) | 0.007 | 1.396 (1.034-6.287) | 0.015 | | Asthma | 1.793 (1.158-5.287) | 0.038 | 1.669 (0.911-3.892) | 0.092 | | B-EOS counts (106/L) | 1.378 (0.895-3.065) | 0.387 | 1.258 (0.913-3.749) | 0.198 | | B-EOS percentage (%) | 2.162 (0.927-6.194) | 0.467 | 1.867 (1.142-5.695) | 0.025 | | T-EOS counts | 2.367 (1.383-9.673) | 0.002 | 2.198 (1.386-8.673) | 0.009 | | T-EOS percentage (%) | 2.980 (1.266-8.574) | <0.001 | 2.679 (1.197-9.266) | 0.001 | | Serum IL-33 level (pg/mL) | 3.769 (1.478-10.269) | <0.001 | 4.451 (1.313-11.672) | <0.001 | | Serum ST2 level (ng/mL) | 3.687 (1.489-10.691) | <0.001 | 3.916 (1.195-12.764) | <0.001 |
|
|
CRSwNP: chronic rhinosinusitis with nasal polyps; B-EOS: blood eosinophil; ST2: suppressor of tumorigenicity 2; OR: odds rate; CI: confidence interval. Adjusted for age, gender, smoking, BMI, atopy, allergic rhinitis, asthma, Lund-Mackay score, Lund-Kennedy score, and VAS score. |
